Correlation Between Sarana Meditama and Millennium Pharmacon

Can any of the company-specific risk be diversified away by investing in both Sarana Meditama and Millennium Pharmacon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarana Meditama and Millennium Pharmacon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarana Meditama Metropolitan and Millennium Pharmacon International, you can compare the effects of market volatilities on Sarana Meditama and Millennium Pharmacon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarana Meditama with a short position of Millennium Pharmacon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarana Meditama and Millennium Pharmacon.

Diversification Opportunities for Sarana Meditama and Millennium Pharmacon

-0.42

Correlation Coefficient

Sarana Meditama  Millennium Pharmacon

Very good diversification

The 3 months correlation between Sarana and Millennium is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Sarana Meditama Metropolitan and Millennium Pharmacon Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Millennium Pharmacon and Sarana Meditama is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarana Meditama Metropolitan are associated (or correlated) with Millennium Pharmacon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Millennium Pharmacon has no effect on the direction of Sarana Meditama i.e., Sarana Meditama and Millennium Pharmacon go up and down completely randomly.

Pair Corralation between Sarana Meditama and Millennium Pharmacon

Assuming the 90 days trading horizon Sarana Meditama Metropolitan is expected to generate 0.97 times more return on investment than Millennium Pharmacon. However, Sarana Meditama Metropolitan is 1.04 times less risky than Millennium Pharmacon. It trades about 0.06 of its potential returns per unit of risk. Millennium Pharmacon International is currently generating about 0.02 per unit of risk. If you would invest  26,200  in Sarana Meditama Metropolitan on September 17, 2024 and sell it today you would earn a total of  2,400  from holding Sarana Meditama Metropolitan or generate 9.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sarana Meditama Metropolitan  vs.  Millennium Pharmacon Internati

Sarana Meditama Metr

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sarana Meditama Metropolitan are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Sarana Meditama may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Millennium Pharmacon

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Millennium Pharmacon International are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward-looking signals, Millennium Pharmacon is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Sarana Meditama and Millennium Pharmacon

The main advantage of trading using opposite Sarana Meditama and Millennium Pharmacon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarana Meditama position performs unexpectedly, Millennium Pharmacon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Millennium Pharmacon will offset losses from the drop in Millennium Pharmacon's long position.

The idea behind Sarana Meditama Metropolitan and Millennium Pharmacon International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..